The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
An international cohort study of cancer in systemic lupus erythematosus
Abstract
Objective: There is increasing evidence in support of an association between systemic lupus erythematosus (SLE) and malignancy, but in earlier studies the association could not be quantified precisely. The present study was undertaken to ascertain the incidence of cancer in SLE patients, compared with that in the general population. Methods: We assembled a multisite (23 centers) international cohort of patients diagnosed as having SLE. Patients at each center were linked to regional tumor registries to determine cancer occurrence. Standardized incidence ratios (SIRs) were calculated as the ratio of observed to expected cancers. Cancers expected were determined by multiplying person‐years in the cohort by the geographically matched age, sex, and calendar year–specific cancer rates, and summing over all person‐years. Results: The 9,547 patients from 23 centers were observed for a total of 76,948 patient‐years, with an average followup of 8 years. Within the observation interval, 431 cancers occurred. The data confirmed an increased risk of cancer among patients with SLE. For all cancers combined, the SIR estimate was 1.15 (95% confidence interval [95% CI] 1.05–1.27), for all hematologic malignancies, it was 2.75 (95% CI 2.13–3.49), and for non‐Hodgkin's lymphoma, it was 3.64 (95% CI 2.63–4.93). The data also suggested an increased risk of lung cancer (SIR 1.37; 95% CI 1.05–1.76), and hepatobiliary cancer (SIR 2.60; 95% CI 1.25, 4.78). Conclusion: These results support the notion of an association between SLE and cancer and more precisely define the risk of non‐Hodgkin's lymphoma in SLE. It is not yet known whether this association is mediated by genetic factors or exogenous exposures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gelman, A., Carlin, J. B., Stern, H. S., & Rubin, D. B. (2003) · doi:10.1201/9780429258480 · Cited by 27,276
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M., Lane, D., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., et al. (2003) · JAMA · doi:10.1001/jama.289.24.3243 · Cited by 1,872
Molecular diversity of arbuscular mycorrhizal fungi colonising arable crops
Daniell, T. (2001) · FEMS Microbiology Ecology · doi:10.1016/s0168-6496(01)00134-9 · Cited by 990
Straus, S. E. (2001) · Blood · doi:10.1182/blood.v98.1.194 · Cited by 464
Beresford, S. A., Weiss, N. S., Voigt, L. F., & McKnight, B. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07365-5 · Cited by 446
Estrogen Replacement Therapy and Ovarian Cancer Mortality in a Large Prospective Study of US Women
Rodriguez, C. (2001) · JAMA · doi:10.1001/jama.285.11.1460 · Cited by 424
Apoptosis: Programmed cell death at a molecular level
Schultz, D. R., & Harringto, W. J. (2003) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2003.50005 · Cited by 356
Risk of malignancy among patients with rheumatic conditions
Thomas, E., Brewster, D. H., Black, R. J., & Macfarlane, G. J. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001101)88:3<497::aid-ijc27>3.0.co;2-j · Cited by 332
Estrogen-Progestin Replacement Therapy and Endometrial Cancer
Pike, M. C., Peters, R. K., Cozen, W., Probst-Hensch, N. M., Wan, P. C., Mack, T. M., & Felix, J. C. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.15.1110 · Cited by 315
Mellemkjér, L., Andersen, V., Linet, M. S., Gridley, G., Hoover, R., & Olsen, J. H. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400424 · Cited by 231
Quality of Care for Patients With Rheumatoid Arthritis
MacLean, C. H. (2000) · JAMA · doi:10.1001/jama.284.8.984 · Cited by 215
Increased risk of cancer in patients with systemic lupus erythematosus.
Pettersson, T., Pukkala, E., Teppo, L., & Friman, C. (1992) · Annals of the Rheumatic Diseases · doi:10.1136/ard.51.4.437 · Cited by 194
Incidence of cancer among patients with systemic sclerosis
Rosenthal, A. K., McLaughlin, J. K., Gridley, G., & Nyrén, O. (1995) · Cancer · Cited by 186
Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus
Björnådal, L., Löfström, B., Yin, L., Lundberg, I. E., & Ekbom, A. (2002) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740252937568 · Cited by 183
Cooper, G. S., Dooley, M. A., Treadwell, E. L., St.Clair, E. W., & Gilkeson, G. S. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10365 · Cited by 182
Self-citationMoss, K. E., Ioannou, Y., Sultan, S. M., Haq, I., & Isenberg, D. A. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.5.409 · Cited by 181
Self-citationBaecklund, E., Sundström, C., Ekbom, A., Catrina, A. I., Biberfeld, P., Feltelius, N., & Klareskog, L. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11144 · Cited by 180
Malignancy in systemic lupus erythematosus
Abu‐Shakra, M., Gladman, D. D., & Urowitz, M. B. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390625 · Cited by 179
Self-citationSystemic lupus erythematosus and the risk of malignancy
Cibere, J., Sibley, J., & Haga, M. (2001) · Lupus · doi:10.1191/096120301678646128 · Cited by 173
Self-citationXu, W., Xiang, Y., Ruan, Z.-X., Zheng, W., Cheng, J., Dai, Q., Gao, Y., & Shu, X. (2003) · International Journal of Cancer · doi:10.1002/ijc.11598 · Cited by 148
Sultan, S. M., Ioannou, Y., & Isenberg, D. A. (2000) · Lara D. Veeken · doi:10.1093/rheumatology/39.10.1147 · Cited by 123
Self-citationIncreased Risk of Malignancy in Patients with Systemic Lupus Erythematosus
Ramsey‐Goldman, R., Mattai, S. A., Schilling, E., et al. (1998) · Journal of Investigative Medicine · doi:10.1177/170882679804600507 · Cited by 114
Self-citationCyclophosphamide for the treatment of systemic lupus erythematosus
Takada, K., Illei, G. G., & Boumpas, D. T. (2001) · Lupus · doi:10.1191/096120301671376017 · Cited by 107
Observation and inference. An introduction to the methods of epidemiology
(1992) · Cancer Causes & Control · doi:10.1007/bf00051660 · Cited by 100
Reproductive Factors and Risk of Intermediate- or High-Grade B-Cell Non-Hodgkin’s Lymphoma in Women
Nelson, R. A., Levine, A. M., & Bernstein, L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1381 · Cited by 76
Nived, O., Bengtsson, A. A., Jönsen, A., et al. (2001) · Lupus · doi:10.1191/096120301678416079 · Cited by 73
Self-citationSafety of Hormonal Replacement Therapy in Postmenopausal Patients with Systemic Lupus Erythematosus
Mok, M. Y. (1998) · Scandinavian Journal of Rheumatology · doi:10.1080/03009749850154357 · Cited by 72
Risk of malignancy in women with systemic lupus erythematosus.
Dm, S., Manzi, S., Janosky, J. E., Kj, S., Ferri, W. A., Ta, M., & Ramsey‐Goldman, R. (1995) · PubMed · Cited by 71
Self-citationMalignancy and systemic lupus erythematosus
Bernatsky, S., Clarke, A. E., & Ramsey‐Goldman, R. (2002) · Current Rheumatology Reports · doi:10.1007/s11926-002-0045-6 · Cited by 57
Self-citationBernatsky, S., Boivin, J., Joseph, L., Pierre, Y. S., Moore, A., Rajan, R., & Clarke, A. E. (2002) · PubMed · Cited by 48
Self-citationObservation and Inference. An Introduction to the Methods of Epidemiology
Jones, D. R. H. (1992) · Journal of Epidemiology & Community Health · doi:10.1136/jech.46.2.174-a · Cited by 48
Hamano, Y., Hirose, S., Ida, A., Abe, M., Zhang, D., Kodera, S., Jiang, Y., Shirai, J., Miura, Y., Nishimura, H., et al. (1998) · Blood · doi:10.1182/blood.v92.10.3772 · Cited by 37
Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus
Bernatsky, S. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh282 · Cited by 31
Self-citation
Cited by
Furie, R., Petri, M., Zamani, O., Cervera, R., Wallace, D. J., Tegzová, D., Sanchez-Guerrero, J., Schwarting, A., Merrill, J. T., Chatham, W. W., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30613 · Cited by 1,683
Self-citationMortality in systemic lupus erythematosus
Bernatsky, S., Boivin, J. ‐., Joseph, L., Manzi, S., Ginzler, E., Gladman, D. D., Urowitz, M., Fortin, P. R., Petri, M., Barr, S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21955 · Cited by 1,181
Self-citationD'Cruz, D. P., Khamashta, M. A., & Hughes, G. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60279-7 · Cited by 992
Bertsias, G., Ioannidis, J. P. A., Boletis, J., Bombardieri, S., Cervera, R., Dostal, C., Font, J., Gilboe, I. M., Houssiau, F., Huizinga, T., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.070367 · Cited by 762
Ekström Smedby, K., Vajdic, C. M., Falster, M., Engels, E. A., Martínez-Maza, O., Turner, J., Hjalgrim, H., Vineis, P., Seniori Costantini, A., Bracci, P. M., et al. (2008) · Blood · doi:10.1182/blood-2007-10-119974 · Cited by 624
Metadata
- Authors
- Bernatsky, S., Boivin, J. F., Joseph, L., Rajan, R., Zoma, A., Manzi, S., Ginzler, E., Urowitz, M., Gladman, D., Fortin, P. R., Petri, M., Edworthy, S., Barr, S., Gordon, C., Bae, S. C., Sibley, J., Isenberg, D., Rahman, A., Aranow, C., Dooley, M. A., Steinsson, K., Nived, O., Sturfelt, G., Alarcón, G., Senécal, J. L., Zummer, M., Hanly, J., Ensworth, S., Pope, J., El‐Gabalawy, H., McCarthy, T., St. Pierre, Y., Ramsey‐Goldman, R., & Clarke, A.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2005-05
- Volume
- 52
- Issue
- 5
- Pages
- 1481-1490
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2039556556
- Cited by
- 353
- References
- 37
- FWCI
- 12.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.